Last reviewed · How we verify
NCT04837599
Artificial Intelligence Performance in Colonoscopy in Daily Practice
NA trial testing Discovery TM of Pentax medical on/off in colonoscopy in Colonic Polyp in 1,100 participants. Status unknown.
31 July 2022
Quick facts
| Lead sponsor | Gastroenterologie Baden-Wettingen |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,100 |
| Start date | 1 August 2021 |
| Primary completion | 31 July 2022 |
| Estimated completion | 31 October 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Discovery TM of Pentax medical on/off in colonoscopy
Conditions studied
- Colonic Polyp — all drugs for Colonic Polyp →
- Adenoma — all drugs for Adenoma →
Sponsor
Gastroenterologie Baden-Wettingen
Who can join
15 and older, any sex, with Colonic Polyp or Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
randomized, controlled single center, single investigator study mainly in colorectal screening population in daily practice with and without artificial intelliegence (AI) named DiscoveryTM from Pentax medical. Patient randomly are allocated to one of four groups: Pentax i10 colonoscopes without any additional device, Pentax i 10 with DiscoveryTM (AI), Pentax i 10 with EndocuffTM and Pentax i10 with EndocuffTM and DiscoveryTM (AI). The different groups are compared in terms of the different parameters: e.g. time of endoscopy, polyps (PDR) and adenoma detected (ADR).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04837599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colonic Polyp
Currently open trials in the same condition.
- NCT06550908 — Training Physicians to Differentiate the Paris Classification Using Artificial Colon Polyp Images · NA · recruiting
- NCT07456111 — A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy · Phase 4 · recruiting
- NCT06483503 — Extra Wide Field of View Lens Study · active not recruiting
- NCT06077435 — Comparative Analysis of AI Software for Enhanced Polyp Detection and Diagnosis · NA · recruiting
Other Gastroenterologie Baden-Wettingen trials
Trials by the same sponsor.
- NCT04472741 — Comparison of Newer Colonoscopy Devices With Standard Forward Viewing (SFV) Colonoscopes in Daily Practice · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04837599 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Gastroenterologie Baden-Wettingen
- Last refreshed: 19 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04837599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing